Healthcare on-demand app CURE raises € 15M in Series-A

The investment will expand CURE’s presence in Germany and open its first international operation in France


Berlin, 22nd August 2022 - CURE Group (known for its app GetCure), a German healthcare on-demand app, announced it has closed a new €15 million series A funding series. French VC Breega led the investment round with the participation of Abstract Ventures, J12 Ventures, and PiLabs. In early January, CURE received a seed investment of € 4,7 million.

The company will use this funding to accelerate its German and France expansion and invest in its healthcare platform to connect patients to telehealth providers, pharmacies, and delivery services. This year, CURE will integrate online consultations on its healthcare platform. In 2023, telemedicine applications such as telediagnostics and telemonitoring will follow.

Founders Ali El-Ali and Manuel Arbele, serial entrepreneurs with a background in tech and mobility industries, set out to disrupt the healthcare industry in Europe by putting the patient at the center of all decision-making. 

“Health has a different meaning for most people than it did a few years ago. Today, physical, mental, emotional, and social health plays a central role in everyday life. No offer or company provides a centralized point of contact for this kind of healthcare. We believe CURE can fill this gap”, said Ali El-Ali, CEO and co-founder of CURE. 

“Our mission is to simplify and be the easiest way for anyone to access healthcare without leaving home. We see ourselves as a healthcare hub, a marketplace that connects all essential services for patients. I believe we are well positioned to help develop and connect the healthcare industry in Germany and across Europe. The role of technology is to help people perform activities more comfortably and agilely, using their 24 hours a day more efficiently. And this is our goal”, adds Manuel, COO and co-founder of CURE.

The company’s business model is constantly growing and sustainably, balancing user acquisition and lifetime value measurement with a monthly burn rate, thus achieving sustainable business development, consciously using cash, and managing its operations. 

For example, CURE proactively took radical decisions to introduce the super lean & cost-efficient hubless business model in the quick commerce & last mile delivery industry for the very first time. This model runs centrally from headquarters with automation and digitization with a high impact on productivity and sustainability of business in all verticals. 

The company has a vision of sustainable and profitable business growth with a calculated business expansion method. The hubless model introduced by CURE will help the whole quick commerce ecosystem to build smart and profitable businesses without heavy assets and complex expansion blueprints. 

One-stop-shop for healthcare

CURE’s marketplace vision is a platform that connects patients to pharmacies, telemedicine providers, and delivery services. Through Cure’s app, people will make a doctor's appointment, receive their digital prescription, and order medications to deliver at home or wherever they want. 

“Our most important goal right now is to digitize our partner's pharmacies and become a crucial partner and platform for them,” explains Ali. The company will gradually evolve its customer and pharmacy app to reach this goal. Nowadays, only non-prescripted (known as over-the-counter) medications can be delivered, but the app will shortly integrate e-prescription.

“The healthcare industry has faced an enormous challenge in the last two years due to Covid and all the impacts it brought to the world, including mental, psychological, and social health. We believe that CURE's vision addresses many of the challenges that arose recently and will drive a profound change in how people interact with the healthcare industry.”, said Isabelle Gallo, Head of Breega's Venture Fund in Europe.

Also, the company will accelerate the hiring process for developers, programmers, data scientists, backend engineering, and all roles that will have a crucial role in developing the best and most reliable healthcare platform in Europe. “It includes other areas such as Marketing, Human Resources, Operations, Commercial, and all departments that will sustain our culture and long-term growth commitment,”, said Manuel.

About Cure

CURE Group GmbH is a healthcare on-demand company with the vision to be the easiest access to healthcare services without leaving your home. Today, CURE works with a local pharmacy network and delivers medicine quickly and sustainably. CURE was founded in December 2021 by Ali El-Ali and Manuel Aberle in Berlin. CURE investors include Breega, Craft Ventures, Abstract Ventures, PiLabs, and J12 Ventures, with participation from J Ventures. For more information, access

About Breega

Breega propels pioneering and purpose-driven founders from idea into impact. We closed our first fund in 2015 and now have +€500m AUM and +70 trailblazing portfolio companies. Crafted for founders by founders, we built Breega to provide start-ups with the help we wish we'd had. And we’ve created an investment proposition that’s purposefully designed. We call it full stack funding: providing capital and connections, expertise and experience, support and solidarity for entrepreneurs at every step of their journey. We invest across Europe and internationally, focusing on pre-seed to Series A stage and above. Get in touch: | Twitter: @BreegaVC | LinkedIn: Breega

... more insights